PROMIS and Mobility Evaluation in Sarcoma Patients
PROMIS and Mobility Evaluation in Sarcoma Patients
Recruiting · NCT07227961 · Registry updated 2025-11-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PROMIS and Mobility Evaluation in Sarcoma Patients | Alzheimer disease, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, bone giant cell tumor, brain disorder, central nervous system disorder, cognitive disorder, connective tissue neoplasm, dementia, giant cell tumor, neoplasm, nervous system disorder, neurodegenerative disease, psychiatric disorder, sarcoma, tauopathy | Recruiting | Not stated | 2025-11-13 | NCT07227961 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mayo Clinic | 970 |
| University of Calgary | 238 |
| University of Toronto | 140 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Foothills Medical Centre, Arthur J Child Comprehensive Cancer Centre, University of Calgary | Calgary | Canada | 1 |
| Mayo Clinic | Rochester | United States | 664 |
| Mayo Clinic | Phoenix | United States | 50 |
| Mount Sinai Hospital, University of Toronto | Toronto | Canada | 1 |